Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

Jan 12, 2024 · Top 25 Biotech Companies of 2024 Combined market cap falls 2% year over year, with 16 of the largest public companies losing value and just 5 outperforming the S&P 500

Aug 23, 2024 · This year, GEN ’s list of top 10 contract development and manufacturing organizations is led by Lonza, which works across five continents and relies on a global …

Feb 1, 2024 · Top 10 Biopharma Takeover Targets of 2024 Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the …

Oct 28, 2024 · Novartis will apply Monte Rosa Therapeutics’ target discovery platform to develop its T and B cell-modulating molecular glue degraders targeting the VAV1 protein—starting with …

Oct 16, 2024 · Pfizer will apply Triana Biomedicines’ target-first and proximity-first discovery platform to discover molecular glue degraders for unspecified “multiple” targets in oncology …

Nov 17, 2021 · GEN’s new updated A-List of top companies in RNA-based biotech encompassing not only developers of vaccines and drugs based on various forms of RNA, but developers of …

Oct 16, 2024 · Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by achieving positive proof-of …

May 31, 2024 · With investments, approvals, and revenues on the rise, gene editing therapy is increasingly able to address delivery and accessibility challenges.

Dec 13, 2024 · Insights into how diverse phage communities coexist within a single E. coli strain could lead to newer, more effective phage-based therapies.